Hunan Warrant PharmaceuticalLtd Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Ben Dong Huang
Chief executive officer
CN¥1.0m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.2yrs |
| CEO ownership | n/a |
| Management average tenure | 3.2yrs |
| Board average tenure | 3.2yrs |
Recent management updates
Recent updates
Is Hunan Warrant PharmaceuticalLtd (SHSE:688799) Using Too Much Debt?
Sep 28
Hunan Warrant Pharmaceutical Co.,Ltd's (SHSE:688799) Price Is Right But Growth Is Lacking
Jul 25Should You Be Adding Hunan Warrant PharmaceuticalLtd (SHSE:688799) To Your Watchlist Today?
Jun 14Hunan Warrant Pharmaceutical Co.,Ltd (SHSE:688799) Held Back By Insufficient Growth Even After Shares Climb 26%
Mar 04CEO
Ben Dong Huang (60 yo)
3.2yrs
Tenure
CN¥1,008,600
Compensation
Mr. Ben Dong Huang is Chairman & GM of Hunan Warrant Pharmaceutical Co.,Ltd from October 26, 2021.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 3.2yrs | CN¥1.01m | no data | |
| Financial Manager & Accounting Supervisor | 3.1yrs | CN¥408.40k | no data | |
| Director & Deputy GM | 3.2yrs | CN¥808.30k | no data | |
| Board Secretary & Deputy GM | 3.2yrs | CN¥508.50k | no data | |
| Core Technical Staff | no data | CN¥305.60k | no data | |
| Core Technical staff | no data | CN¥329.00k | no data |
3.2yrs
Average Tenure
49yo
Average Age
Experienced Management: 688799's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 3.2yrs | CN¥1.01m | no data | |
| Director & Deputy GM | 3.2yrs | CN¥808.30k | no data | |
| Chairman of the Board of Supervisors | 3.2yrs | no data | 2.53% CN¥ 97.7m | |
| Vice Chairman | no data | CN¥508.30k | 16.63% CN¥ 641.8m | |
| Director | 3.2yrs | CN¥80.00k | no data | |
| Independent Director | 3.2yrs | CN¥80.00k | no data | |
| Independent Director | 3.2yrs | CN¥80.00k | no data | |
| Supervisor | 3.2yrs | no data | no data | |
| Employee Representative Supervisor | 3.2yrs | no data | no data | |
| Independent Director | 2.7yrs | CN¥80.00k | no data |
3.2yrs
Average Tenure
54.5yo
Average Age
Experienced Board: 688799's board of directors are considered experienced (3.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 10:06 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hunan Warrant Pharmaceutical Co.,Ltd is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhu Chen | Citic Securities Co., Ltd. |
| Kai Wang | Citic Securities Co., Ltd. |